Clinical trial
(ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early…
NCT00354341 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00354341 |
|---|---|
| Title | (ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy |
| Official title | An Open, Randomized, Multi-centre Trial to Investigate the Effect of Anemia Correction on Cardiac Structure and Function in Patients With Early Diabetic Nephropathy |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Epoetin beta |
| Enrollment | 170 |
| Start date | Sep 1, 2002 |
| Primary completion | Jul 1, 2005 |
| Completion | Jul 1, 2005 |
| First posted | Jul 20, 2006 |
| Last update posted | Mar 31, 2016 |
| Countries | Austria, Brazil, Czechia, Denmark, Finland, Germany, Greece, Hungary, Italy, Mexico, Poland, Russia and 5 more |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: